107. Immunotherapy. 2018 Feb 1;10(4):247-250. doi: 10.2217/imt-2017-0171.Where do the immune checkpoint inhibitors stand in the management of triplenegative breast cancer?Rassy EE(1), Karak FE(1), Ghosn M(1).Author information: (1)Department of Medical Oncology, Hotel Dieu de France University Hospital,Faculty of Medicine, Saint Joseph University, Beirut, Lebanon.DOI: 10.2217/imt-2017-0171 PMID: 29421978 